Gary Schaer to Cell- and Tissue-Based Therapy
This is a "connection" page, showing publications Gary Schaer has written about Cell- and Tissue-Based Therapy.
Connection Strength
0.544
-
Clinical Benefits of Stem Cells for Chronic Symptomatic Systolic Heart Failure: A Systematic Review of the Existing Data and Ongoing Trials. Cell Transplant. 2016 11; 25(11):1911-1923.
Score: 0.140
-
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study. Cell Transplant. 2016; 25(9):1701-1711.
Score: 0.135
-
Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial. Lancet. 2016 Jun 11; 387(10036):2412-21.
Score: 0.134
-
The ixCELL-DCM Trial: Rationale and Design. Cell Transplant. 2016; 25(9):1689-1699.
Score: 0.134